Inhibikase Therapeutics
Price & Volume
Stats
See more52W Range | $1.13-$4.20 |
Market Cap | $120.7M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $1 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$27.1M |
Diluted EPS | -$0.04 |
News
See moreYahoo Finance • last month
These stocks are moving in today's pre-market session
Yahoo Finance • last month
Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
Yahoo Finance • 3 months ago
Inhibikase Therapeutics shareholders elect directors and approve equity plan changes
Yahoo Finance • 3 months ago
Ludwig Enterprises appoints Garth Lees-Rolfe as independent director
About
CEO | Mr. Mark T. Iwicki |
Address | 3350 Riverwood Parkway SE, Atlanta, GA, United States, 30339 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 15 |
